We conducted a cohort study of adult ward patients who had a Medical Emergency Team (MET) call triggered by confirmed or suspected sepsis in an Australian tertiary centre to assess the predictive utility of systemic inflammatory response syndrome (SIRS) and quick Sepsis-Related Organ Failure Assessment (qSOFA) scores for 28-day mortality over a 12-month period. Sepsis was the causative aetiology in 970 MET calls for 646 patients with a mean age of 68 years and median Charlson Comorbidity score (CCS) of 3.0. Four hundred and seven (63%) patients had microbiological identification of a causative organism with 35 (9%) demonstrating multi-drug resistance. The 28-day mortality rate was 22%. Independent risk factors for 28-day mortality included age (incidence rate ratio [IRR] 1.038; P <0.001) and CCS (IRR 1.102; P <0.001). qSOFA positive patients had a threefold risk of 28-day mortality compared to those who were negative (IRR 3.15; P=0.02). Both the SIRS and qSOFA score had poor sensitivity (86% versus 62%, respectively) for mortality as a sole diagnostic tool and should be investigated as part of a multiparameter panel within a large prospective study.
Summary
We conducted a cohort study of adult ward patients who had a Medical Emergency Team (MET) call triggered by confirmed or suspected sepsis in an Australian tertiary centre to assess the predictive utility of systemic inflammatory response syndrome (SIRS) and quick Sepsis-Related Organ Failure Assessment (qSOFA) scores for 28-day mortality over a 12-month period. Sepsis was the causative aetiology in 970 MET calls for 646 patients with a mean age of 68 years and median Charlson Comorbidity score (CCS) of 3.0. Four hundred and seven (63%) patients had microbiological identification of a causative organism with 35 (9%) demonstrating multi-drug resistance. The 28-day mortality rate was 22%. Independent risk factors for 28-day mortality included age (incidence rate ratio [IRR] 1.038; P <0.001) and CCS (IRR 1.102; P <0.001). qSOFA positive patients had a threefold risk of 28-day mortality compared to those who were negative (IRR 3.15; P=0.02). Both the SIRS and qSOFA score had poor sensitivity (86% versus 62%, respectively) for mortality as a sole diagnostic tool and should be investigated as part of a multiparameter panel within a large prospective study.
Key Words: sepsis, hospital rapid response team, systemic inflammatory response syndrome, risk assessment, mortality Sepsis is the leading cause of mortality in critically ill inpatients 1 . The Surviving Sepsis Campaign (SSC) was established after the Barcelona Declaration in 2002 to reduce the mortality of those admitted with sepsis, which was documented as high as 37% in their cohort of 15,022 subjects 2 . There is no targeted anti-sepsis treatment. The key emphasis from the SSC campaign was early identification and initiation of appropriate therapy to reduce mortality [3] [4] [5] [6] . The early identification of sepsis remains clinically elusive due to the lack of a gold standard diagnostic test and the poor performance of clinical definitions proposed by expert opinion panels.
The 2016 Third International Consensus Definitions for Sepsis (Sepsis-3) was released to help address these deficiencies through the establishment of updated definitions, including the Sepsis-Related (or Sequential) Organ Failure Assessment (SOFA) and the bedside quick SOFA (qSOFA) scores 7 
. The Third International Consensus
Definitions Task Force recommended use of a qSOFA score of two points or more in non-intensive care unit settings to consider the possibility of sepsis. There is clinical debate regarding the concurrent validity of qSOFA. Furthermore, these criteria were validated in the USA health system and it is unclear how these criteria may be extrapolated to other well-resourced healthcare systems such as those in Australia and the UK.
Quach et al demonstrated that sepsis, when diagnosed at Medical Emergency Team (MET) calls, was associated with double the mortality of those without sepsis 8 . We assessed the performance of qSOFA in the MET call population, due to the higher frequency of mortality, which would create sufficient power for robust comparisons of its predictive utility. Our aim was to characterise the predictive value of qSOFA for 28-day mortality following MET call activation for sepsis in an Australian non-intensive care unit patient context.
Materials and methods

Study design
The Monash Health Human Research Ethics Committee approved this retrospective cohort study as a quality improvement exercise (#16115Q). Monash Health (MH) is a 2,170-bed network of five acute and subacute hospitals with two intensive care units (ICUs) with 34 beds. MH is the second largest health network in Australia. Patients who experienced a MET call between 1 January 2015 and 31 December 2015 were included based on events identified by the MET team in an MH log ( Figure 1 ).
MET system
The MET system is a rapid response system that operates 24 hours a day at MH and is attended by a medical registrar, ICU nurse and physician. MET calls can be triggered by any staff member, for patients with vital signs outside set parameters, or general concern regarding a patient's condition (Appendix A). All MET calls are logged for quality purposes monthly.
Study sample
Medical records were reviewed and correlated with the patient scanned medical record database to identify those with evidence of sepsis. In this study, we defined sepsis as confirmed or suspected infection with either one major criterion or two minor criteria (Appendix B). Patients ≥18 years of age from medical, surgical or mental health units were included for review. Those who had a repeat MET call during the same admission were limited to the initial MET call fulfilling our sepsis definition. Patients who had an inadvertent MET call when they were documented as not for MET calls were excluded. Patients who were assessed as not appropriate for ICU admission by the treating team after MET call activation were included.
Data collection
Admission diagnosis, Charlson Comorbidity Score (CCS) 9 and history of immunosuppressant or antibiotic use was documented as per the senior registrar as well as presumed or confirmed source of infection. Designation of chronic kidney disease (CKD) stage was performed using estimated glomerular filtration rate (eGFR) calculated via the modification of diet in renal disease formula 10 . Healthcare-associated infection (HAI) definitions were taken as per the European Centre for Disease Prevention and Control surveillance survey 11 . Vital signs including heart rate (HR), systolic blood pressure (SBP) and respiratory rate (RR) were recorded at presentation to hospital and at the time of MET call. Relevant biochemical variables such as albumin, International Normalized Ratio (INR), lactate, white cell count (WCC), eosinophils, C-reactive protein (CRP), bilirubin, creatinine and microbiological growth were noted at admission and at the time of MET call, and whether the patient fulfilled sepsis criteria ≥6 hours prior to MET call.
Outcome variables
The primary outcome was 28-day, in-hospital mortality. Secondary outcomes included ICU admission, need for inotropic or ventilatory support, whether the patient was made not for resuscitation (NFR) post-MET call, and repeat MET call within 24 hours. Physiological data recorded at the time of the MET call was used to calculate patients' systemic inflammatory response syndrome (SIRS) and qSOFA scores 7,12 .
Statistical methods
Analysis was performed using IBM SPSS Grad Pack version 24.0 (Chicago, IL, USA). Continuous variables were described using mean ± standard deviation or median and interquartile range (IQR) if the data was parametric or non-parametric, respectively. Categorical data were summarised as absolute numbers and percentages. Fisher's exact text was used to assess differences in mortality rates between groups. Paired t-test was used to assess change in clinical and biochemical markers from baseline to time of MET call. Poisson regression analysis was utilised to assess the predictors of 28-day mortality due to the relative frequency of the primary endpoint in order to provide direct relative risk estimates. Univariate analysis was applied to clinical and biochemical predictors of mortality, with multivariate analysis applied to predictors with a P-value <0.10. Survival was calculated using Kaplan-Meier statistics. The kappa coefficient was used to measure the agreement between the two sepsis definitions. A two-tailed P-value ≤0.05 was considered statistically significant. 
Results
Study population
MH logged 4,496 MET calls in the 2015 calendar year. Sepsis was identified as the trigger in 970 (22%) MET calls. Of these, 646 were included in our study as unique sepsisrelated MET calls ( Table 1 ). The mean age was 68.4±17.6 years and 335 (52%) were males. Most sepsis-related MET calls occurred in medical patients (84%). Two hundred and seventy-three sepsis-related MET calls occurred afterhours and 166 were during weekends (42% and 26%, respectively).
Multiple comorbidities were identified in our study population, with a median CCS of 3 (IQR 1.25 to 6.00). Ninety-two (14%) patients were on concurrent immunosuppression. Participants who were qSOFA positive were more likely to be older (70.15±16.74 versus 67.28±17.80 years; P=0.04), hypotensive (SBP 108±70.03 versus 126±36.38 mmHg; P <0.01) and have a higher CCS (median 4 [IQR 2 to 6] versus 3 [IQR 1 to 5], P=0.01) than those who were qSOFA negative. Lower respiratory tract infections were the most common source of sepsis with 218 (34%) patients and genitourinary sepsis was the second most common with 123 (19%) patients. One hundred and twentythree (19%) cases resulted from a hospital-acquired infection.
Microbial culture was positive in 407 (63%) patients, with bacterial organisms the most predominant (87%) organisms grown (Appendix C). Multi-drug-resistant organisms constituted 9% of those grown, with 24 (6%) cases of Those who went on to have a positive culture were more likely to have an infectious aetiology as their admission diagnosis (64% versus 54%, P=0.01) and have a higher CRP (151±108.40 versus 130±98.36 mg/l; P=0.02). Both the SIRS and qSOFA risk scores were not predictive of microbiological growth (P=0.61 and P=0.24, respectively).
Change from baseline
There was a statistically significant difference between median SBP (125 versus 111 mmHg), HR (91 versus 112 /minute) RR (19 versus 27 /minute), albumin (31 versus 27 g/l) and CRP (79 versus 127 mg/l) from admission to time of MET call respectively (all P-values <0.01). White cell count was also significantly elevated from admission: 10.70 versus 11.85 x 10 9 /l (P=0.05). There was no significant difference between eosinophil count, creatinine, lactate, bilirubin or INR from admission to time of the MET call (Appendix D). Five hundred and thirty-six (83%) patients were on antibiotics at the time of MET call, whilst 593 (92%) were treated with antibiotics post-MET call.
Primary and secondary outcomes
One hundred and forty (22%) patients died within 28 days of their first sepsis-related MET call. One hundred and thirtyeight (21%) patients had a repeat MET call within 48 hours and 99 (15%) patients were palliated post-MET call. Two hundred (31%) patients required ICU admission, with 118 (18%) and 112 (17%) on inotropic and ventilatory support, respectively. The median length of stay was 15 days (95% confidence interval [CI] 7 to 33). Only CCS was predictive for prolonged length of stay (β coefficient 2.26, P=0.03) and the need for transfer to ICU (incidence rate ratio [IRR] 0.90, P=0.04).
Predictors of 28-day mortality
Univariate analysis (Appendix E) demonstrated eight factors which were significant for 28-day mortality: age, CCS, INR, Glasgow Coma Scale (GCS) score, lactate, bilirubin, SIRS positive and qSOFA positive ( Table 2 ). There was no significant difference in eosinophil counts (0.13 versus 0.12 x 10 9 /l; P=0.706), CRP (140.832 versus 144.986 mg/l; P=0.693), change in creatinine from baseline (8.40 versus 8.41%; P=0.998), blood glucose level [BSL] (8.46 versus 8.39 mmol/l; P=0.856) or albumin levels (26.63 versus 27.39 g/l; P=0.286) between those who died and those who survived. There was no significant difference in mortality based on gender (P=0.445) or MET call timing (P=0.218), however, time from admission to their first MET call was increased in those who subsequently died (four versus two days, P=0.004). On multivariate analysis, five of these variables were found to be independent predictors of mortality. The strongest predictor of mortality was being both SIRS and qSOFA positive.
SIRS versus qSOFA
Five hundred and ten (79%) participants were SIRS positive (median 2, 95% CI 2.27 to 2.42), whereas 278 (43%) were qSOFA positive (median 1, 95% CI 1.38 to 1.49). Forty-nine (8%) patients were qSOFA positive but SIRS negative. Of those who were qSOFA positive, 87 (31%) were culture positive. SIRS positivity had an IRR of 2.468 (P=0.017) for mortality, whereas qSOFA positivity had an IRR of 3.151 (P=0.008) ( Figure 2 ). Being both SIRS and qSOFA positive conferred the highest risk with IRR 4.096 compared to those who were not (P <0.001). The two sepsis definitions had poor interscore correlation, with 240 (37%) patients fulfilling both risk scores, with overall agreement of 51% and kappa statistic of 0.096 (95% CI 0.041 to 0.152). Neither score was sensitive for mortality, with a sensitivity of 86.42% (positive predictive value [PPV] 23.73%, negative predictive value [NPV] 86.03%) and 62.14% (PPV 31.29%, NPV 85.06%) for the SIRS and qSOFA scores respectively (Figure 3 ). Being both SIRS and qSOFA positive had a PPV of 48.05% and NPV of 84.21%.
Only CCS was predictive for prolonged length of stay (β coefficient 2.26, P=0.03). Neither SIRS nor the qSOFA scores were predictive of the need for ICU admission (IRR 1.00, P=0.99 and IRR 0.88, P=0.79, respectively) or a prolonged length of stay (β coefficient -0.37, P=0.92 and IRR -12.66, P=0.21 respectively).
Serum lactate
Serum lactate >2.0 mmol/l was able to discriminate between survivors and non-survivors (25% versus 17%; P=0.04). When serum lactate (grouped as <2, 2-4, >4 mmol/l) was combined with the qSOFA score the predictive value was not significantly increased compared to qSOFA alone (area under the receiver operating curve [AUROC] 0.67 versus 0.64, P=0.49). 
Discussion
In this study, we assessed the predictive utility of qSOFA positivity for non-ICU inpatient prognostication and identified other clinical variables, which independently predicted 28-day mortality in non-ICU patients. Our patient population is representative of clinical practice with older age and multiple comorbidities. The qSOFA was derived and validated by Seymour et al in a large patient cohort with suspected or confirmed infection 13 . Our results were discordant with the original qSOFA validation study as the relative risk for mortality was much higher in those who were qSOFA positive compared to those who were SIRS positive. Application of the bedside qSOFA test could miss 38% of patients who have deteriorated on the ward due to sepsis or to inappropriate antibiotic treatment of those who have deteriorated from non-sepsis-related aetiologies.
The proponents of the qSOFA score argue that it can enhance the detection of those at risk of mortality from sepsis even if it is not sensitive for the primary diagnosis of sepsis per se. However, we found the sensitivity of both the qSOFA and SIRS to be poor, even as a predictor of mortality or need for ICU admission, in this highly-selected cohort of critically ill septic patients. Both the SIRS and qSOFA risk scores were unable to reliably exclude sepsis, with poor sensitivity in relation to mortality. Even more alarmingly, it has the potential to miss sepsis as the driver for physiological deterioration in 57% of non-ICU patients who had a MET call for sepsis. The qSOFA score may engender a false sense of mortality prediction without any direct clinical benefit to our patients. It is unclear to us how patient outcomes could be improved from adopting these re-definitions of sepsis which are poorly predictive of sepsis as a primary driver for patient deterioration on the ward. The qSOFA may remain just a research tool, and our paper adds to the current clinical reservations in regard to the widespread adoption of the qSOFA score. The addition of serum lactate to the qSOFA score did not improve its performance, as has been demonstrated previously 14 , and confirms the rationale for its exclusion by the original Sepsis-3 task force. This highlights the need for a multiparameter bedside tool to distinguish those who have sepsis at the time of a MET call. The qSOFA sensitivity in this highly-selected patient population of culture positive patients was low, which suggests that the predictive validity of the qSOFA is limited when applied to an unwell non-ICU patient population already being treated for infection. Our study reported a high frequency of isolates in 63% of patients, which is much higher than the usual quoted range of 20% to 40% 15 , though not dissimilar to the large European SOAP study 16 . The inability to retrospectively distinguish between colonisation and pathological organisms may also contribute to the high microbial culture rate observed in our study. Gram-negative organisms were responsible for more than half the isolates seen, with high rates of Enterobacteriaciae urinary isolates identified. Rates of MRSA and ESBL infection were not dissimilar to those found by Zhanel et al 17 ; however, rates of VRE were much higher in our population. It is unclear whether the rate of VRE seen here is reflective of causative infection, or enhanced hospital screening for colonisation.
This study merits consideration of its limitations. Our criteria included only those patients with confirmed or suspected infection, and as such, we are unable to assess the useability of the different definitions to diagnose infection in critically ill patients. It is not possible to assess whether these scores would be able to accurately recognise early cases of sepsis prior to MET call. We also failed to exclude patients who had limitations set on their care, which could influence the cases of mortality seen in this study. The predictive power of the two risk scores still requires further validation in a larger, prospective cohort.
In this study of 646 patients who had a MET call for sepsis, those who were qSOFA positive had a three-fold risk of 28-day mortality compared to qSOFA negative patients. On multivariate analysis, qSOFA score was a stronger predictor for 28-day mortality in a non-ICU setting than the SIRS score. However, the qSOFA score had poor sensitivity as a sole diagnostic tool for excluding sepsis and should be investigated as part of a multiparameter panel incorporating other clinical variables. 
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